These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 52887)

  • 1. Antibody response in C3H mice injected with CBA lymphoid cells as detected by membrane immunofluorescent staining.
    Lilliehöök B; Blomgren H
    Scand J Immunol; 1975; 4(4):321-5. PubMed ID: 52887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specifically decreased MLC response of lymphocytes from CBA mice injected with cells from the H-2-compatible, M-antigen-incompatible strain C3H. Lack of such effect after injection of H-2-disparate C3H-hybrid cells.
    Lilliehöök B; Jacobsson H; Blomgren H
    Scand J Immunol; 1975; 4(3):209-16. PubMed ID: 125450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of lymphocyte activating determinants from recognition sites in mouse MLR.
    Abbasi K; Festenstein H; Verbi W; Roitt IM
    Nature; 1974 Sep; 251(5472):227-9. PubMed ID: 4138667
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced capacity to produce specific 'effector' cells after injection of CBA mice with C3H cells.
    Lilliehöök B; Jacobsson H; Blomgren H
    Scand J Immunol; 1975 Sep; 4(5-6):463-9. PubMed ID: 241116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial tolerant state against H-2 disparate cells. No impaired specific reactivity in MLC, GVH, or antibody production.
    Jacobsson H; Lilliehöök B; Blomgren H
    Scand J Immunol; 1976; 5(8):949-54. PubMed ID: 11549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance of specifically mlc-responsive lymphocytes in cba mice injected with cells from the h-2-compatible, m-antigen-incompatible strain c3h.
    Jacobsson H; Lilliehöök B; Blomgren H
    Scand J Immunol; 1975; 4(2):181-92. PubMed ID: 124943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.
    Staerz UD; Rammensee HG; Benedetto JD; Bevan MJ
    J Immunol; 1985 Jun; 134(6):3994-4000. PubMed ID: 2580901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F1-hybrid anti-parental-strain reactivity. II. Proliferation of C3H X CBA hybrid lymphocytes in the spleens of irradiated CBA mice.
    Blomgren H; Lilliehöök B
    Scand J Immunol; 1978; 8(3):231-7. PubMed ID: 151911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An isotopic antiglobulin test for quantitation of anti-sheep red blood cell antibodies of individual Ig classes in mice bearing different IgCH haplotypes.
    Haber J; Winn HJ
    J Immunol Methods; 1982; 48(1):61-74. PubMed ID: 6173443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of stem cells by lymphocytes nonlinked to the H-2 histocompatibility system.
    Petrov RV; Seslavina LS; Pantelejev EI; Yegorova OS
    Transplant Proc; 1977 Mar; 9(1):555-7. PubMed ID: 325792
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymocyte-stimulating factor from peripheral blood cells.
    Sabato GD; Altin M; Chen DM
    Cell Immunol; 1977 May; 30(2):204-15. PubMed ID: 140769
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic regulation of the antibody response to H-2Db alloantigens in mice. IV. Antigens that activate helper T cells for IgG, coded for by the non-H-2 genome.
    Wernet D; Heinrichs H; Wernet P
    J Immunol; 1982 Jun; 128(6):2595-8. PubMed ID: 6176646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of xenogeneic and allogeneic antisera specific for mouse thymus-derived lymphocytes.
    Bron C; Anckers C; Sauser D
    Eur J Immunol; 1976 Aug; 6(8):594-8. PubMed ID: 61881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacity of C3H X CBA spleen cells to depress the MLC response of CBA mice specifically. Evidence for an active role of the injected cells.
    Jacobsson H; Lilliehöök B; Blomgren H
    Cell Immunol; 1976 Mar; 22(1):53-65. PubMed ID: 132274
    [No Abstract]   [Full Text] [Related]  

  • 17. [Formation of antibodies against the antigen-recognizing receptors of T-lymphocytes in a syngenous system].
    Nesterenko VG; Cherniakhovskaia IIu
    Biull Eksp Biol Med; 1977 Dec; 84(12):693-5. PubMed ID: 304363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new differentiation antigen (FT-1) shared with fetal thymocytes and leukemic cells in the mouse.
    Kasai M; Takashi T; Takahashi T; Tokunaga T
    J Exp Med; 1984 Apr; 159(4):971-80. PubMed ID: 6608576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxic cells in NZB mice: spontaneous in vivo and in vitro primed activity and structural characteristics.
    Croker BP; Zinkernagel RM; Dixon FJ
    Clin Immunol Immunopathol; 1979 Apr; 12(4):410-24. PubMed ID: 222522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inactivation of allogeneic stem cells by lymphocytes identical as regards the H2 system of tissue compatibility].
    Petrov RV; Egorov IK; Seslavina LS; Panteleev EI; Egorova OS
    Dokl Akad Nauk SSSR; 1974; 219(6):1489-91. PubMed ID: 4155671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.